LOC100132004: A Drug Target / Disease Biomarker (G100132004)

LOC100132004: A Drug Target / Disease Biomarker

LOC100132004 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to increased levels of thermal stress in the cells.

One of the unique features of LOC100132004 is its ability to interact with other proteins, particularly the protein known as HSP70. HSP70 is a well-known protein that is involved in a variety of cellular processes, including stress response, DNA damage repair, and cell signaling.

Research has suggested that LOC100132004 may be a drug target or biomarker for a variety of diseases, including heart disease, neurodegenerative diseases, and cancer. This is because of its ability to interact with HSP70, as well as its expression in various tissues of the body.

One potential mechanism by which LOC100132004 may be involved in the development of heart disease is its role in stress response. HSP70 is well-known for its ability to interact with various transcription factors and cytoskeletal proteins, which are involved in regulating cellular processes that are critical for heart function.

Research has suggested that LOC100132004 may be involved in the regulation of cellular stress responses, which could lead to an increased risk of heart disease. This is because of its ability to interact with HSP70, as well as its expression in the heart muscle.

Another potential mechanism by which LOC100132004 may be involved in the development of neurodegenerative diseases is its role in the regulation of cellular signaling pathways. HSP70 is well-known for its ability to interact with various signaling proteins, including those involved in neurotransmitter signaling.

Research has suggested that LOC100132004 may be involved in the regulation of neurotransmitter signaling pathways, which could lead to an increased risk of neurodegenerative diseases. This is because of its ability to interact with HSP70, as well as its expression in the brain.

In addition to its potential role in heart disease and neurodegenerative diseases, LOC100132004 may also be involved in the development of cancer. This is because of its expression in various tissues of the body, including the liver, which is a common site for cancer development.

Research has suggested that LOC100132004 may be involved in the regulation of cellular signaling pathways that are critical for cancer growth and progression. This is because of its ability to interact with HSP70, as well as its expression in the liver.

Overall, LOC100132004 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its ability to interact with HSP70, as well as its expression in various tissues of the body, makes it an attractive candidate for further research.

While more research is needed to fully understand the role of LOC100132004 in disease, its potential as a drug target or biomarker is an exciting area of study. As research continues to progress, it is likely that we will learn more about the mechanisms by which LOC100132004 functions and its potential role in the development of disease.

Protein Name: Ankyrin Repeat Domain 30B Pseudogene

The "LOC100132004 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100132004 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053